CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- 4 Open-market buy CEO and CFO bought 1,000 shares at $19.99 ($19,990)
- 4 Open-market buy VP Clinical Reg. Affairs bought 1,000 shares at $19.99 ($19,990)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $19.99 ($19,990)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO and CFO bought 2,050 shares at $23.82 ($48,831)
- 4 Open-market buy CEO and CFO bought 1,840 shares at $27.17 ($49,992)
- 4 Open-market buy Chief Medical Officer bought 1,111 shares at $26.99 ($29,983)
- 4 Open-market buy Director bought 200 shares at $27.56 ($5,512)
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Other events
Page 10 of 14 · 279 filings